|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Deconstructing a disease:RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia显示文摘 | Melnick A Licht JD | 1999 | Blood1999，93，10： | 1 |
| 2 | Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia显示文摘 | Melnick A Licht JD | 1999 | Blood1999，93，： | 1 |
| 3 | Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?显示文摘 | JOHNSTONE RW LICHT JD | 2003 | Cancer Cell2003，4，1： | 1 |
| 4 | HOX deregulation in acute myeloid leukemia显示文摘 | Rice KL Licht JD | 2007 | J Clin Invest2007，117，4： | 1 |
| 5 | Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target显示文摘 | Johnstone RW Licht JD | 2003 | Cancer Cell2003，4，1： | 1 |
| 6 | Reconstructing a disease : What essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia? 显示文摘 | Licht JD | 2006 | Cancer Cell2006，9，2： | 1 |
| 7 | The WT1 Wilms tumor suppressor gene :how much do we really know显示文摘 | Reddy JC Licht JD | 1996 | Biochem Biophys Acta1996，1287，1： | 1 |
| 8 | Deconstructing a disease: RAR{alpha}, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia显示文摘 | Melnick A Licht JD | 1999 | Blood1999，93，48： | 1 |
| 9 | The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation 显示文摘 | Johnstone RW Licht JD Nan X | 2003 | Biol Chem2003，278，6： | 1 |
| 10 | Deconstructing a disease:RAPalpha,its fusion partners,and their roles in the pathogenesis of acute promyelocytic leukemia显示文摘 | Melnick A Licht JD | 1999 | Blood1999，93，10： | 1 |
| 11 | AMLI and the AML1-ETO fusion protein in the pathogenesis of t(8, 21) AML显示文摘 | Licht JD | 2001 | Oncogene2001，20，19： | 1 |
| 12 | WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak显示文摘 | Morrison DJ English MA Licht JD | 2005 | Cancer Res2005，65，18： | 1 |
| 13 | Deconstructing a disease:RAR α,its fusion partners,and their roles in the pathogenesis of acute promyelocytic leukemia 显示文摘 | Melnick A Licht JD | 1999 | Blood1999，93，： | 1 |
| 14 | Gastrointestinal sarcomas显示文摘 | Licht JD Weissmann LB Antman K | 1988 | Semin oncol1988，15，2： | 1 |
| 15 | Histone deacetylase inhibitors in cancer therapy:Is transcription the primary target显示文摘 | Johnstone RW Licht JD | 2003 | Cancer Cell2003，4，： | 1 |
| 16 | Ponatinib- a step forward in overcoming resistance in chronic myeloid leukemia显示文摘 | FRANKFURT O LICHT JD | 2013 | Clin Cancer Res2013，19，19： | 1 |
| 17 | Transcription factors, normal myeloid development, and leukemia 显示文摘 | Tenen DG Hromas R Licht JD | 1997 | Blood1997，90，2： | 1 |
| 18 | Histone deacetylases as therapeutic targets in hematologic malignancies 显示文摘 | Melnick A Licht JD | 2002 | Curr Opin Hematol2002，9，4： | 1 |
| 19 | Deconstructing a disease:RAR alpha,its fusion partners and their roles in the pathogenesis of acute promyelocytic leukemia显示文摘 | Melnick A Licht JD | | 0，，10： | 1 |
| 20 | Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2 delta, the unique DNA binding and transactivation properties 显示文摘 | Zhao F Satoda M Licht JD | 2001 | J Biol Chem2001，276，40： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员